Omoconazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302322This classification denotes an antifungal agent with the molecular formula C20H17Cl3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GQ8ADD54E1, chemically known as 1h-imidazole, 1-(2-(2-(4-chlorophenoxy)ethoxy)-2-(2,4-dichlorophenyl)-1-methylethenyl)-, (z)- but generally known as omoconazole, which bears US NIH Compound Identifier 3033988. European Medicines Agency schedules Omoconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09442MIG. World Health Organization schedules omoconazole in its Anatomical Therapeutic Chemical (ATC) Classification. OMOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule omoconazole under HS 29332990 and SITC 51573. As of Q4 2014, OMOCONAZOLE remains the US FDA Preferred Term for this commodity. Omoconazole bears US NLM identifiers UMLS ID C0069488 and NCI Concept Code C74599. SMILES: CLC1C(C(=C(\N2CCNC2)C)\OCCOC2CCC(CL)CC2)CCC(CL)C1.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.